-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The patient Wang Moumou, male, 27 years old, went to the outpatient clinic on July 8, 2021 because of "hearing people's words out of thin air, the suspect followed up for the persecution for July, which was aggravated by 2 weeks"
History of present illness
History of present illnessStarting from January 2021, no obvious incentives have gradually appeared.
Past history
Past historyIn May 2021, it was diagnosed as "hypertension grade I"
Personal history
Personal historyUsually outgoing personality and strong working ability
Family history
Family historyDeny family history
Admission check
Admission checkThe vital signs are stable, blood pressure 120/80 mmHg, height 1.
Mental examination
Mental examinationClear consciousness, complete orientation, passive contact, age-matched appearance, questionable answers, nervous expression, eliciting auditory hallucinations, relationship and persecution delusions, and mild depression
Laboratory examination
Laboratory examinationThere were no abnormalities in hematuria, blood biochemistry, HIV and syphilis, antibody testing, electrocardiogram, thyroid function test, and head MRI
diagnosis
diagnosisParanoid schizophrenia; hypertension grade I, intermediate-risk group
Diagnose based on
Diagnose based onThe patient is a young male with a medical history of six months.
Differential diagnosis
Differential diagnosisIf the patient has no history of serious physical disease and brain trauma, organic mental disorders and physical mental disorders can be ruled out
Medication process
Medication processJuly 9-July 15: Lurasidone 40 mg qd (taken with breakfast), diazepam 2.
The follow-up on July 15th, the lazy movement improved, and I was able to communicate with my family
July 16-July 22: Lurasidone 40 mg bid (with breakfast and dinner), diazepam 2.
Follow-up on July 22: Able to go out with friends
July 23-30: Lurasidone 40 mg bid (with breakfast and dinner), diazepam 2.
Follow-up on July 30: Able to go out with friends and do housework
.
Auditory hallucinations and delusions rarely occur
.
Sitting still does not disappear, blood pressure is stable, and weight does not increase
.
The liver and kidney function was rechecked, and the electrocardiogram was not special
.
During the whole treatment process, rTMS treatment was supplemented
.
At present, the patient has been treated for 5 weeks, the condition is stable, no hallucinations and delusions appear again, he is resting at home, able to do housework, and looks neat and tidy
.
Currently taking Lurasidone 40 mg bid (with breakfast and dinner) and Metoprolol 12.
5 mg po qd
.
Amlodipine has been gradually reduced and stopped
.
The blood pressure was stable and the weight did not increase
.
Experience
ExperienceLurasidone has a quick onset and good effect on the positive and negative symptoms of SCZ
.
But be careful to take it with meals, and there may be adverse reactions of akathisia
.
Antipsychotics should consider metabolic risk from the beginning
.
During the treatment, the patient's weight, blood pressure, blood sugar, and blood lipid levels should be actively tested, and if there are changes, the dressing should be considered
.
Leave a message here